SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran's potential blockbuster heart drug
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pat Sims who wrote (13)12/27/1996 11:52:00 PM
From: Chuca Marsh   of 27
 
Pat, in the Annual of CYTO-Quadramet is Pharma(cokinetic?) described as combo of nuclear(stable complex of radioactive samarium & tetraphosphonate chelator EDTMP), chemical and biologic properties that provide safe and rapid relief of pain for the patient.The therapeutic component emits both a beta particle and a gamma photon(as imaging element) and has a physical half-life of 46.3 hours.
Of special interest here is the fact that in a call to their I.R. in New Jersey, they told me of a foreign study in their phase III clinicals that
have shown safe and effective indications for a form of arthrithis. This
again is a significant factor and as with all newclassofdrugsbiotech
companies, like Nortran, and NRT's neighbor Inflazyme, one drug indication may in the future be expanded upon in the future by other
unexpected resultants. For weeks I have been saying on Cyto posts-
to take 2 Quadramets and see the results on your headache(ha,ha).
In fact earlier tonite ,I quiped on Inflazyme to take 2 Bispans and see
the results on .... etc(their Arhrithis "lead indication")
The point of the 2 classes of Nortrans Patented "lead Indications"
may in fact in the future LEAD to other more or less spectactular or
efficient OTHER remeady(s).
P.S. in looking up this info in 3 Annual Reports , I just noticed some GOOD news - When CYTO has Quadramet approved by FDA
a milestone payment of $2,000,000 is due them. I have better refer
to this post on the CYTO thread-you might get some look-see-folks.
The "Original" name for Quadramet in 1994 was Samarium EDTMP.
Allen-this sure would confuse a look-up /quick research that you did.
But on the other hand , I 'm glad things change because Quadramet
is a much better name and to expand the indications with no fanfare
in the Oct 96 10Q report that I keyed into is just an example of the
"Multiplicity of Future Uses" for an aware & a "heads up" Discovery and Research company such as al of you "NEWCLASSOFDRUGSBIOTECHS".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News